| OK, OK, we'll look at another vaccine stock! We've been deluged with questions about the slickly produced Money Morning pitch about a breakthrough "Super Vaccine" stock recommended by Michael Robinson, so that's the Thinkolator's task for today -- what's the stock, and is it worth your time? I can at least answer the first part of that question, just click below to... |
